Epigenome editing in cancer: Advances and challenges for potential therapeutic options

Seung Won Lee, Connor Mitchell Frankston, Jungsun Kim

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cancers are diseases caused by genetic and non-genetic environmental factors. Epigenetic alterations, some attributed to non-genetic factors, can lead to cancer development. Epigenetic changes can occur in tumor suppressors or oncogenes, or they may contribute to global cell state changes, making cells abnormal. Recent advances in gene editing technology show potential for cancer treatment. Herein, we will discuss our current knowledge of epigenetic alterations occurring in cancer and epigenetic editing technologies that can be applied to developing therapeutic options.

Original languageEnglish (US)
Title of host publicationEpigenetic Regulation of Cancer - Part B
PublisherElsevier Inc.
Pages191-230
Number of pages40
DOIs
StatePublished - Jan 2024

Publication series

NameInternational Review of Cell and Molecular Biology
Volume383
ISSN (Print)1937-6448

Keywords

  • Epigenetic alterations
  • Epigenetic therapeutic options
  • Epigenome editing

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Epigenome editing in cancer: Advances and challenges for potential therapeutic options'. Together they form a unique fingerprint.

Cite this